Design, Molecular docking, Synthesis and Biological evaluation of 5, 7 dimethyl pyrido(2, 3-d)pyrimidin-4-one and 4,5 dihydro pyrazolo (3, 4-d) pyrimidines for cytotoxic activity

Design, Molecular docking, Synthesis and Biological evaluation of 5, 7 dimethyl pyrido(2, 3-d)pyrimidin-4-one and 4,5 dihydro pyrazolo (3, 4-d) pyrimidines for cytotoxic activity M. Sathish Kumar Research Scholar, Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies, VISTAS, Pallavaram, Chennai - 600117 Tamilnadu, India M. Vijey Aanandhi Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies, VISTAS, Pallavaram, Chennai - 600117 Tamilnadu, India

The fused pyrimidine derivatives are potent tyrosine kinase and thymidylate synthase inhibitors. The compound 3-(4-sulphonyl amino)-2-methyl thio-6-phenyl azo-5, 7-dimethyl pyrido(2,3-d)pyrimidin-4-one was synthesized from Ethyl 2-amino-4,6-dimethylpyridine-3-carboxylate, benzene diazonium chloride, benzene sulphonyl amino isothiocyanate in subsequent reactions. 1-(1, 3-benzothiazol-2-yl)-3-methyl-4-phenyl-1H-pyrazolo[3,4-d]pyrimidines were synthesized from 1, 3-benzothiazole, 2-thiol, Hydrazine Hydrate, 2-hydrazinyl-1, 3-benzothiazole and aldehydes in subsequent reactions. Twenty-five derivatives pyrimidine scaffolds were designed and performed molecular docking studies for the ability to inhibit the target protein using molecular docking simulation, selective compounds were synthesized and characterized by spectral methods. All the synthesized compounds evaluated for their antioxidant activity and MTT assay exhibited compounds 13c, 13e and 14d can be potential anticancer candidates against MCF-7, Hep G2 and Hela cell lines respectively. Based on all the studies conclude that good agreement was observed between the top-ranked docking scores and top experimental inhibitors when compared with standards ascorbic acid and imatinib. Hence, the compounds could be considered as new anticancer hits for further lead optimization.
6 29 2021 6 29 2021 3029 3038 10.52711/0974-360X.2021.00530 https://rjptonline.org/AbstractView.aspx?PID=2021-14-6-20 10.1016/j.bioorg.2018.03.030 Tageldin GN, Fahmy SM, Ashour HM, Khalil MA, Nassra RA, Labouta IM. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents. Bioorg Chem 2018; 78: 358-71. 10.2174/1389557511307010070 Shah SS, Rivera G, Ashfaq M. Recent advances in medicinal chemistry of sulfonamides. Rational design as anti-tumoral, anti-bacterial and anti-inflammatory agents. Mini Rev Med Chem 2013; 13: 70-86. 10.1016/j.bmcl.2012.03.092 Keche AP, Hatnapure GD, Tale RH, Rodge AH, Birajdar SS, Kamble VM. Novel pyramidine derivatives with aryl urea, thiourea and sulfonamide moieties: Synthesis, anti- inflammatory and antimicrobial evaluation. Bioorg Med Chem Lett 2012; 22: 3445-8. 10.1002/ardp.200800223 Rostom SA, Ashour HM, Abd El Razik HA. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents. Arch Pharm (Weinheim) 2009; 342: 299-310. Nassar E, El-Badry YA, Eltoukhy AM, Ayyad RR. Synthesis, in vitro antitumor and antimicrobial activity of some pyrazoline, pyridine and pyrimidine derivatives linked to indole moiety. J Am Sci 2010; 6: 463-71. 10.2174/1570162x17666190911125359 Hajimahdi Z, Zabihollahi R, Aghasadeghi MR, Zarghi A. Design, Synthesis, Docking Studies and Biological Activities Novel 2, 3-Diaryl-4-Quinazolinone Derivatives as Anti-HIV-1 Agents. Current HIV research. 2019 May 1; 17(3): 214-22. 10.1002/chin.200720204 Gadhachanda VR, Wu B, Wang Z, Kuhen KL, Caldwell J, Zondler H, et al. 4-Amino-pyrimidines as novel HIV-1 inhibitors. Bioorg Med Chem Lett 2007; 17: 260-5. 10.1016/j.bmc.2012.10.019 Pretorius SI, Breytenbach WJ, de Kock C, Smith PJ, N’Da DD. Synthesis, characterization and antimalarial activity of quinoline–pyrimidine hybrids. Bioorg Med Chem 2013; 21: 269-77. 10.1021/jm5004528 Oliveira R, Guedes RC, Meireles P, Albuquerque IS, Gonçalves LM, Pires E, Bronze MR, Gut J, Rosenthal PJ, Prudêncio M, Moreira R. Tetraoxane–pyrimidine nitrile hybrids as dual stage antimalarials. Journal of Medicinal Chemistry. 2014 Jun 12; 57(11) :4916-23. 10.1016/j.ejmech.2016.08.039 Mishra S, Singh P. Hybrid molecules: The privileged scaffolds for various pharmaceuticals. European Journal of Medicinal Chemistry. 2016 Nov 29; 124: 500-36. 10.1016/j.ejmech.2011.01.013 Rashad AE, Mahmoud AE, Ali MM. Synthesis and anticancer effects of some novel pyrazolo [3, 4-d] pyrimidine derivatives by generating reactive oxygen species in human breast adenocarcinoma cells. European Journal of Medicinal Chemistry. 2011 Apr 1; 46(4): 1019-26. 10.1016/j.ejmech.2016.09.023 Akhtar J, Khan AA, Ali Z, Haider R, Yar MS. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities. European journal of medicinal chemistry. 2017 Jan 5; 125: 143-89. 10.1039/c0md00116c Kamal A, Reddy JS, Ramaiah MJ, Dastagiri D, Bharti EV, Sagar MV, et al. Design, synthesis and biological evaluation of imidazopyridine/ pyrimidinechalcone derivatives as potential anticancer agents. Med Chem Commun 2010; 1: 355-60. 10.1016/j.ejmech.2014.12.013 Shi JB, Tang WJ, Li R, Liu XH. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: Synthesis and anticancer activity. Eur J Med Chem 2015; 90: 889-96. 10.1021/jm0309957 Wang S, Meades C, Wood G, Osnowski A, Anderson S, Yuill R, Thomas M, Mezna M, Jackson W, Midgley C, Griffiths G. 2-Anilino-4-(thiazol-5-yl) pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activity. Journal of Medicinal Chemistry. 2004 Mar 25; 47(7): 1662-75. 10.1002/anie.201309576 Joshi T, Pierroz V, Mari C, Gemperle L, Ferrari S, Gasser G. A Bis (dipyridophenazine)(2‐(2‐pyridyl) pyrimidine‐4‐carboxylic acid) ruthenium (II) Complex with Anticancer Action upon Photodeprotection. Angewandte Chemie International Edition. 2014 Mar 10; 53(11): 2960-3. 10.1016/j.bmcl.2013.03.129 Kamal A, Tamboli JR, Nayak VL, Adil SF, Vishnuvardhan MV, Ramakrishna S. Synthesis of pyrazolo [1, 5-a] pyrimidine linked aminobenzothiazole conjugates as potential anticancer agents. Bioorganic and Medicinal Chemistry Letters. 2013 Jun 1; 23(11): 3208-15. 10.3390/molecules25010042 Secrieru A, O’Neill PM, Cristiano ML. Revisiting the Structure and Chemistry of 3 (5)-Substituted Pyrazoles. Molecules. 2020 Jan; 25(1):42. 10.1186/s13065-018-0406-5 Kumar S, Narasimhan B. Therapeutic potential of heterocyclic pyrimidine scaffolds. Chemistry Central Journal. 2018 Dec 1;12(1): 38. 10.1039/c2ob27003j Deadman BJ, Hopkin MD, Baxendale IR, Ley SV. The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib. Organic and Biomolecular Chemistry. 2013; 11(11): 1766-800. 10.3390/molecules23123369 Zhao LM, Guo Z, Xue YJ, Min JZ, Zhu WJ, Li XY, Piao HR, Jin CH. Synthesis and evaluation of 3-substituted-4-(quinoxalin-6-yl) pyrazoles as TGF-β type I receptor kinase inhibitors. Molecules. 2018 Dec; 23(12): 3369. 10.1016/j.ejmech.2010.03.047 Bacelar AH, Carvalho MA, Proença MF. Synthesis and in vitro evaluation of substituted pyrimido [5, 4-d] pyrimidines as a novel class of Antimycobacterium tuberculosis agents. European Journal of Medicinal Chemistry. 2010 Jul 1; 45(7): 3234-9. 10.1016/j.bmcl.2004.03.013 Schenone S, Bruno O, Ranise A, Bondavalli F, Brullo C, Fossa P, Mosti L, Menozzi G, Carraro F, Naldini A, Bernini C. New pyrazolo [3, 4-d] pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation. Bioorganic and Medicinal Chemistry Letters. 2004 May 17; 14(10): 2511-7. 10.1016/j.bmc.2012.09.019 Matyugina E, Khandazhinskaya A, Chernousova L, Andreevskaya S, Smirnova T, Chizhov A, Karpenko I, Kochetkov S, Alexandrova L. The synthesis and antituberculosis activity of 5′-nor carbocyclic uracil derivatives. Bioorganic and Medicinal Chemistry. 2012 Nov 15; 20(22): 6680-6. 10.1016/j.bmcl.2014.02.012 Siddiqui AB, Trivedi AR, Kataria VB, Shah VH. 4, 5-Dihydro-1H-pyrazolo [3, 4-d] pyrimidine containing phenothiazines as antitubercular agents. Bioorganic and Medicinal Chemistry Letters. 2014 Mar 15; 24(6): 1493-5. 10.1016/j.bmc.2012.01.029 Gangjee A, Zaware N, Raghavan S, Yang J, Thorpe JE, Ihnat MA. N4-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo [2, 3-d] pyrimidines as potent multiple receptor tyrosine kinase inhibitors: Design, synthesis, and in vivo evaluation. Bioorganic and Medicinal Chemistry. 2012 Apr 1; 20(7): 2444-54. 10.1016/j.bmc.2012.05.068 Gangjee A, Zhao Y, Ihnat MA, Thorpe JE, Bailey-Downs LC, Kisliuk RL. Novel tricyclic indeno [2, 1-d] pyrimidines with dual antiangiogenic and cytotoxic activities as potent antitumor agents. Bioorganic and Medicinal Chemistry. 2012 Jul 15; 20(14): 4217-25. 10.1016/j.ejmech.2014.06.027 Fares M, Abou-Seri SM, Abdel-Aziz HA, Abbas SE, Youssef MM, Eladwy RA. Synthesis and antitumor activity of pyrido [2, 3-d] pyrimidine and pyrido [2, 3-d][1, 2, 4] triazolo [4, 3-a] pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest. European Journal of Medicinal Chemistry. 2014 Aug 18; 83: 155-66. 10.1002/cmdc.201800719 Kalyukina M, Yosaatmadja Y, Middleditch MJ, Patterson AV, Smaill JB, Squire CJ. TAS‐120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure. Chem Med Chem. 2019 Feb 19; 14(4): 494-500. 10.1016/j.ejmech.2012.10.006 Loidreau Y, Marchand P, Dubouilh-Benard C, Nourrisson MR, Duflos M, Lozach O, Loaec N, Meijer L, Besson T. Synthesis and biological evaluation of N-arylbenzo [b] thieno [3, 2-d] pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors. European Journal of Medicinal Chemistry. 2012 Dec 1; 58: 171-83. 10.1016/j.ejmech.2009.07.013 Said SA, Amr AE, Sabry NM, Abdalla MM. Analgesic, anticonvulsant and anti-inflammatory activities of some synthesized benzodiazipine, triazolopyrimidine and bis-imide derivatives. European Journal of Medicinal Chemistry. 2009 Dec 1;44(12): 4787-92. 10.1134/s106816201504007x El Azab IH, Khaled KM. Synthesis and reactivity of enaminone of naphtho [b] 1, 4-oxazine: One pot synthesis of novel isolated and heterocycle-fused derivatives with antimicrobial and antifungal activities. Russian Journal of Bioorganic Chemistry. 2015 Jul 1; 41(4): 421-36. 10.1080/00397911.2016.1165254 Roopan SM, Sompalle R. Synthetic chemistry of pyrimidines and fused pyrimidines: A review. Synth Commun 2016; 46: 645-72. 10.1007/s00044-011-9915-7 Raghunath SA, Manjunatha Y, Rayappa K. Synthesis, antimicrobial, and antioxidant activities of some new indole analogues containing pyrimidine and fused pyrimidine systems. Med Chem Res 2012; 21: 3809-17. 10.1002/jhet.843 Aly AA, Ramadan M, Mohamed AM, Ishak EA. Thieno[2, 3-d]pyrimidines in the synthesis of new fused heterocyclic compounds of prospective antitumor and antioxidant agents. J Heterocyclic Chem 2012; 49: 1009-18. 10.3390/molecules13041011 Abunada NM, Hassaneen HM, Kandile NG, Miqdad OA. Synthesis and biological activity of some new pyrazoline and pyrrolo [3, 4-c] pyrazole-4, 6-dione derivatives: reaction of nitrilimines with some dipolarophiles. Molecules 2008; 13: 1011-24. 10.1016/j.fjps.2016.02.002 Ismail NS, Ibrahim DA, Serya RA. Pyrazolo [3, 4-d] pyrimidine based scaffold derivatives targeting kinases as anticancer agents. Future J Pharm Sci 2016; 2: 20-30. 10.1002/chin.201131152 Shanmugasundaram P, Aanandini MV, M Satish. Synthesis and biological evaluation of pyrido(2, 3-d)pyrimidine- carboxylate derivatives. Ind J Chem 2011; 50B: 284-9. 10.1039/c4ra09768h Kumar D, Khan SI, Tekwani BL, Diwan PP, Rawat S. 4-Aminoquinoline-pyrimidine hybrids: Synthesis, antimalarial activity, heme binding and docking studies. Eur J Med Chem 2015; 89: 490-502. 10.15254/h.j.d.med.10.2018.177 B.C. Revanasiddappa, M. Vijay Kumar, Hemanth Kumar, Synthesis and antioxidant activity of novel pyrazoline derivatives, Hygeia.J.D.Med.10 (1) August 2018; 43-49 Rahul. R, Rakesh Kumar Jat, J. Saravanan, Synthesis, and invitro antioxidant activity of novel 1, 3, 4-oxadiazole-2-thione, JIPBS, Vol 3(3), 114-122, 2016 10.1016/j.fitote.2014.03.003 Venkanna, B. Siva, B. Poornima, P.R. Rao Vadaparthi, K. Rajendra Prasad, K. Ashok Reddy, G. Bhanu Prakash Reddy, K. Suresh Babu, Phytochemical investigation of sesquiterpenes from the fruits of Schisandrachinensis and their cytotoxic activity, Fitoterapia 95 (2014) 102–108.